LJIN KNOWS ABOUT AUPH and ALL THE Voc STORIES DEFINATELY BETTER THAN the munipulators/short hedge funds' employees. ILJIN has Dr. Hyuek Joon Lee on AUPH's board of directors. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20% or 5,185,185 shares of the 25,645,000 shares offered at $6.7 publicly on 03-13-2017? ILJIN knows AUPH shares are GOLD BAGS based on Voc 's phase 2 results updated in early 2017, doesn't it? ILJIN owns 17.35% of AUPH (14,205,457 shares) now.
LJIN KNOWS ABOUT AUPH and ALL THE Voc STORIES DEFINATELY BETTER THAN the munipulators/short hedge funds' employees. ILJIN has Dr. Hyuek Joon Lee on AUPH's board of directors. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20% or 5,185,185 shares of the 25,645,000 shares offered at $6.7 publicly on 03-13-2017? ILJIN knows AUPH shares are GOLD BAGS based on Voc 's phase 2 results updated in early 2017, doesn't it? ILJIN owns 17.35% of AUPH (14,205,457 shares) now.
"I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next ARIA. I buy and hold AUPH the way I bought and held ARIA. I'm planning to add more AUPH shares now that the Glickman-Cramer interview has offered a new opportunity. I always picked/pick up the gold bags of ARIA/AUPH shares whenever the price was/is right to me. I like cheapened gold bags."
Stellar management team, great science, Aspreva success, stellar VOC P2 results, expertise in trial design, FDA Fast Track status, etc. I simply believe that when you add it all up, it significantly boosts their odds of success in P3.